VNDAVanda PharmaceuticalsVNDA info
$4.62info-1.07%24h
Global rank15510
Market cap$265.10M
Change 7d-2.94%
YTD Performance10.00%
SP500 benchmarkUnderperform
P/E115.50
P/S1.38
Revenue$192.64M
Earnings$2.51M
Dividend yield-
Main Sector
Healthcare

Vanda Pharmaceuticals (VNDA) Stock Overview

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its pipeline products include HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, delayed sleep phase disorder, sleep disturbances in autism spectrum disorder, and pediatric Non-24; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist to treat gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia. The company's pipeline products also include VTR-297, a small molecule histone deacetylase inhibitor to treat hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist to treat performance anxiety and psychiatric disorders; VHX-896, an active metabolite of iloperidone; and antisense oligonucleotide molecules. In addition, it offers a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110 for the treatment of dry eye and ocular inflammation; and VPO-227 for the treatment of secretory diarrhea disorders comprising cholera. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

VNDA Stock Information

Symbol
VNDA
Address
2200 Pennsylvania Avenue NWWashington, DC 20037United States
Founded
-
Trading hours
-
Website
https://www.vandapharma.com
Country
πŸ‡ΊπŸ‡Έ United States
Phone Number
202 734 3400

Vanda Pharmaceuticals (VNDA) Price Chart

-
Value:-

Vanda Pharmaceuticals Overview: Key Details and Summary

Stock data
2023
Change
Price
$4.62
N/A
Market Cap
$265.10M
N/A
Shares Outstanding
57.38M
1.63%
Employees
290.00
N/A
Valuation
2023
Change
P/E Ratio
115.50
N/A
P/S Ratio
1.38
N/A
Earnings
2023
Change
Revenue
$192.64M
N/A
Earnings
$2.51M
N/A
EPS
0.04
N/A
Earnings Yield
0.0087
N/A
Gross Margin
0.9232
N/A
Operating Margin
-0.0724
N/A
Net income margin
0.013
N/A
logo
Facebook Icon
Twitter Icon
Linkedin Icon
Β© 2024 Topstocks.org